1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Viscosupplementation Overview
3 Products under Development
3.1 Viscosupplementation – Pipeline Products by Stage of Development
3.2 Viscosupplementation – Pipeline Products by Segment
3.3 Viscosupplementation – Pipeline Products by Territory
3.4 Viscosupplementation – Pipeline Products by Regulatory Path
3.5 Viscosupplementation – Pipeline Products by Estimated Approval Date
3.6 Viscosupplementation – Ongoing Clinical Trials
4 Viscosupplementation – Pipeline Products under Development by Companies
4.1 Viscosupplementation Companies – Pipeline Products by Stage of Development
4.2 Viscosupplementation – Pipeline Products by Stage of Development
5 Viscosupplementation Companies and Product Overview
5.1 Ampio Pharmaceuticals Inc Company Overview
5.1.1 Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anika Therapeutics Inc Company Overview
5.2.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Carticept Medical Inc Company Overview
5.3.1 Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Chi2Gel Ltd. Company Overview
5.4.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cocoon Biotech, Inc. Company Overview
5.5.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Flex Biomedical Inc Company Overview
5.6.1 Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Herng Shan Co Ltd Company Overview
5.7.1 Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Kalvista Pharmaceuticals Inc Company Overview
5.8.1 Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 KiOmed Pharma Company Overview
5.9.1 KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview
5.10 Lineage Cell Therapeutics Inc Company Overview
5.10.1 Lineage Cell Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medytox Inc Company Overview
5.11.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Moebius Medical Ltd Company Overview
5.12.1 Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 OPKO Health Inc Company Overview
5.13.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Shin Poong Pharm Co Ltd Company Overview
5.14.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 University of Kansas Company Overview
5.15.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
6 Viscosupplementation- Recent Developments
6.1 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
6.2 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19
6.3 Apr 06, 2020: New Jersey Chiropractor agrees to pay $2 million to resolve allegations of unnecessary knee injections and knee braces and related kickbacks
6.4 Feb 04, 2020: Seikagaku: Consolidated financial results for the first nine months of fiscal 2019
6.5 Dec 18, 2019: Bioventus to provide Blue Cross Blue Shield of Michigan with preferred options for knee osteoarthritis patients
6.6 Dec 03, 2019: KalVista Pharmaceuticals reports fiscal second quarter results
6.7 Dec 02, 2019: Fidia Introduces in the US the 3-injection regimen TRILURON (sodium hyaluronate)
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
Table 1: Viscosupplementation - Pipeline Products by Stage of Development
Table 2: Viscosupplementation - Pipeline Products by Segment
Table 3: Viscosupplementation - Pipeline Products by Territory
Table 4: Viscosupplementation - Pipeline Products by Regulatory Path
Table 5: Viscosupplementation - Pipeline Products by Estimated Approval Date
Table 6: Viscosupplementation - Ongoing Clinical Trials
Table 7: Viscosupplementation Companies - Pipeline Products by Stage of Development
Table 8: Viscosupplementation - Pipeline Products by Stage of Development
Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Ampion - Product Status
Table 11: Ampion - Product Description
Table 12: Ampion - Hand Osteoarthritis - Product Status
Table 13: Ampion - Hand Osteoarthritis - Product Description
Table 14: Ampio Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 15: Ampion - A Randomized, Controlled, Double-blind Study to Evaluate the Efficacy and Safety of an Intra-articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee
Table 16: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Cingal - Product Status
Table 18: Cingal - Product Description
Table 19: Hyaluronic Acid - Synovial Joints - Product Status
Table 20: Hyaluronic Acid - Synovial Joints - Product Description
Table 21: MONOVISC - Hip - Product Status
Table 22: MONOVISC - Hip - Product Description
Table 23: ORTHOVISC-T - Product Status
Table 24: ORTHOVISC-T - Product Description
Table 25: Sodium Hyaluronate - Osteoarthritis - Product Status
Table 26: Sodium Hyaluronate - Osteoarthritis - Product Description
Table 27: Anika Therapeutics Inc - Ongoing Clinical Trials Overview
Table 28: Cingal - A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)
Table 29: Cingal - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (CINGAL) to Provide Symptomatic Relief of Osteoarthritis of Ankle Joint
Table 30: MONOVISC - Hip - A Prospective Study of a Single Injection Cross-linked Sodium Hyaluronate (Monovisc) to Provide Symptomatic Relief of Osteoarthritis of Hip Joint
Table 31: MONOVISC - Hip - Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip
Table 32: ORTHOVISC-T - A Prospective, Open-label, Multi-center Post-market Clinical Follow-up Study to Evaluate the Residual Risk of OrthoVisc-T (OVT) in the Treatment of Chronic Lateral Epicondylosis (Tennis Elbow)
Table 33: Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Agilus - Product Status
Table 35: Agilus - Product Description
Table 36: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Chi2Knee - Product Status
Table 38: Chi2Knee - Product Description
Table 39: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Silk Hydrogel - Product Status
Table 41: Silk Hydrogel - Product Description
Table 42: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Flex Polymer - Product Status
Table 44: Flex Polymer - Product Description
Table 45: Herng Shan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Hyalease 16 and 20 - Product Status
Table 47: Hyalease 16 and 20 - Product Description
Table 48: Hyalease 8 - Product Status
Table 49: Hyalease 8 - Product Description
Table 50: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Viscosupplementation - Pipeline Products by Stage of Development
Figure 2: Viscosupplementation - Pipeline Products by Segment
Figure 3: Viscosupplementation - Pipeline Products by Territory
Figure 4: Viscosupplementation - Pipeline Products by Regulatory Path
Figure 5: Viscosupplementation - Pipeline Products by Estimated Approval Date
Figure 6: Viscosupplementation - Ongoing Clinical Trials